✦ LIBER ✦

Leucocyte doubling time is a useful predictor of progression-free survival in chronic lymphocytic leukaemia

✍ Scribed by U. AXDORPH; B. I. NILSSON; B. R. NILSSON; M. BJÖRKHOLM

Book ID: 114742867
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 395 KB
Volume: 237
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.1995.tb01162.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beta2-microglobulin is a better predicto

Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate

✍ Julio Delgado; Guy Pratt; Neil Phillips; Javier Briones; Chris Fegan; Josep Nomd 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

CD49d expression is an independent predi

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

✍ Tait D. Shanafelt; Susan M. Geyer; Nancy D. Bone; Renee C. Tschumper; Tom E. Wit 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Using parametric survival curves to esti

Using parametric survival curves to estimate progression free survival in a netowrk meta-analyis of treatments for chronic lymphocytic leukemia

✍ Devine, B; Cheng, MM 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Minimal Residual Disease Quantification

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

✍ Bottcher, S.; Ritgen, M.; Fischer, K.; Stilgenbauer, S.; Busch, R. M.; Fingerle- 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 272 KB

Consolidation with alemtuzumab improves

Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

✍ Carmen D. Schweighofer; Matthias Ritgen; Barbara F. Eichhorst; Raymonde Busch; W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB